Elsevier Commits to Accelerate AI-Driven Science Across Europe

Elsevier, a global leader in advanced information and decision support in science and healthcare, today announced its pledge to the European Commission's AI in Science Enablers Initiative.

Elsevier's contribution spans complimentary access to its AI-powered research and clinical tools, funded research collaborations, and training for the next generation of AI-literate researchers and clinicians, reflecting the company's mission to help advance science and healthcare to advance human progress.

The pledge was announced at the AI in Science Summit in Dublin, which brought together over 1,000 participants from the research, technology, business, and policy communities to launch the Commission's initiative to mobilize private-sector and philanthropic support for European science.

Elsevier AI solutions

Elsevier will make available 4,000 complimentary licenses for European researchers, healthcare professionals and students:

• 1,000 LeapSpace™ licenses for early-career and senior researchers, alongside a proposed Europe-wide Challenge to be developed with the Commission. LeapSpace is a research-grade AI workspace that helps researchers carry out complex tasks across their complete workflows.

• 1,000 ClinicalKey AI licenses. ClinicalKey AI is an EHR and API-enabled clinical decision support tool designed to quickly surface the latest evidence at the point of care.

• 1,000 ClinicalKey Nursing AI licenses. ClinicalKey Nursing AI is a clinical AI tool built specifically for nurses and designed to support both point of care decision-making and professional growth across the nursing career journey.

• 1,000 Complete Anatomy licenses. Complete Anatomy is the world's most advanced 3D anatomy platform.

Research collaboration and training

• Alongside these licenses, Elsevier is committing an estimated €1m a year of in-kind support and funding to strengthen Europe's AI research talent pipeline and to advance responsible, AI-centered research:

• At least three new collaborations per year with European research institutions, drawing on in-kind support from Elsevier's data science, ethics and software development experts, alongside access to its content suite and knowledge discovery tools.

• Participation in the Horizon-funded AIRIS project, which supports AI-enabled hypothesis generation in biomedicine.

• Establishment of a new Centre on Hybrid Intelligence for Trustworthy Research, in partnership with the University of Amsterdam and Vrije Universiteit Amsterdam.

• Training and career development for approximately 10 PhD candidates, postdoctoral researchers and master’s students in AI per year, through programs across the company.

Kumsal Bayazit, CEO, Elsevier, said: “Europe's world-leading researchers and clinicians are working at the frontier of AI, and they need platforms and partnerships they can trust. Through this pledge, Elsevier is bringing the full breadth of its capabilities to that effort — funded collaborations, training for the next generation of scientists, and research-grade AI and clinical solutions for better outcomes. We're proud to support the European Commission's AI in Science Enablers Initiative and to help build an AI research ecosystem for Europe that is innovative, responsible, and sustainable.”

Elsevier will continue to work with the European Commission to refine the details of its pledge, including the scope of the LeapSpace Challenge, in the weeks following the Summit. To apply for complimentary access to Elsevier’s AI-powered research and clinical tools, please visit: www.elsevier.com/promotions/eu-ai-science-enablers-portal.

About the AI in Science Enablers Initiatives

The AI in Science Enablers Initiative is a European Commission initiative to maximize the impact of private-sector and philanthropic support for the European research community, and to make these initiatives as visible and accessible as possible to researchers and scientific organizations across Europe.

About Elsevier

エルゼビアは、先端情報と意思決定支援の分野におけるグローバルリーダーです。1世紀以上にわたり、科学と医療の発展を通じて人類の進歩に貢献してきました。世界170か国において、学術・企業の研究コミュニティ、医師、看護師、将来の医療従事者、教育関係者の重要な活動を支援しています。エルゼビアは、世界有数のエビデンスに基づく科学・医学コンテンツ、精度の高いAI、そして専門家による評価を基盤とした研究・臨床レベルのソリューションを提供し、より良い成果の実現を支援しています。また、サービスを提供するコミュニティと連携しながら、多様性とサステナビリティの推進にも取り組んでいます。エルゼビア財団opens in new tab/window（Elsevier Foundation）は、世界各地における研究および医療分野のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールを提供するグローバル企業、RELXopens in new tab/windowの一員です。詳細については、https://www.elsevier.com/ja-jp をご覧いただくか、ソーシャルメディアの @elsevierconnect をご参照ください。